isoprenaline hydrochloride medsurge isoprenaline hydrochloride 1.0 mg/5 ml injection solution ampoule
medsurge pharma pty ltd - isoprenaline hydrochloride, quantity: 1 mg - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid; sodium chloride; disodium edetate; sodium citrate dihydrate; citric acid - isoprenaline hydrochloride is indicated: for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy.,for serious episodes of heart block and adams-stokes attacks (except when caused by ventricular tachycardia or fibrillation). (see section 4.3 contraindications),for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available. (see section 4.3 contraindications.),for bronchospasm occurring during anaesthesia.,as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cardiogenic shock. (see section 4.4 special warnings and precautions for use).
isoprenaline hydrochloride medsurge isoprenaline hydrochloride 0.2 mg/1 ml injection solution ampoule
medsurge pharma pty ltd - isoprenaline hydrochloride, quantity: 200 microgram - injection, solution - excipient ingredients: sodium citrate dihydrate; sodium hydroxide; hydrochloric acid; sodium chloride; disodium edetate; citric acid; water for injections - isoprenaline hydrochloride is indicated: for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy.,for serious episodes of heart block and adams-stokes attacks (except when caused by ventricular tachycardia or fibrillation). (see section 4.3 contraindications),for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available. (see section 4.3 contraindications.),for bronchospasm occurring during anaesthesia.,as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cardiogenic shock. (see section 4.4 special warnings and precautions for use).
isoprenaline macure 0.2 mg/ml concentrate for solution for infusion
macure pharma aps hejrevej 39, dk-2400 copenhagen nv , denmark - isoprenaline hydrochloride - concentrate for solution for infusion - isoprenaline hydrochloride 0.2 mg/ml - cardiac therapy
isoprenaline hydrochloride macure 0.2 mg/ml concentrate for solution for infusion
macure pharma aps - isoprenaline hydrochloride - concentrate for solution for infusion - 0.2 milligram(s)/millilitre - isoprenaline
isoprenaline phagecon 1 mg/5 ml, concentrate for solution for infusion. st
phagecon - serviços e consultoria farmacêutica, lda. avenida josé malhoa, nº2 edifício malhoa plaza, 3º piso, escritório 3.7 1070-325 lisboa , portugal - isoprenaline hydrochloride - concentrate for solution for infusion - isoprenaline hydrochloride 1 mg/5ml - cardiac therapy
isoprenaline hcl macure 0.2 mg/ml inf. sol. (conc.) i.v. amp.
macure pharma aps - isoprenaline hydrochloride 0,2 mg/ml - eq. isoprenaline 0,17 mg/ml - concentrate for solution for infusion - 0,2 mg/ml - isoprenaline hydrochloride 0.2 mg/ml - isoprenaline
isoprenaline macure isoprenaline hydrochloride 1 mg/5 ml solution for injection ampoule
juno pharmaceuticals pty ltd - isoprenaline hydrochloride, quantity: 1 mg - injection, solution - excipient ingredients: sodium citrate dihydrate; water for injections; sodium hydroxide; hydrochloric acid; sodium chloride; citric acid monohydrate; disodium edetate - for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy. for serious episodes of heart block and adams-stokes attacks (except when caused by ventricular tachycardia or fibrillation). (see section 4.3 contraindications.) for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available. (see section 4.3 contraindications.) for bronchospasm occurring during anaesthesia. as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cardiogenic shock. (see section 4.4 special warnings and precautions for use)
hospira isoprenaline hydrochloride injection isoprenaline hydrochloride 1 mg/5 ml injection ampoule
pfizer australia pty ltd - isoprenaline hydrochloride -
hospira isoprenaline hydrochloride injection isoprenaline hydrochloride 200 microgram/1 ml injection ampoule
pfizer australia pty ltd - isoprenaline hydrochloride -
isoprenaline hydrochloride monico 0.2mg/1ml
monico spa via ponte di pietra 7, 30173, venice, italy - isoprenaline hydrochloride - solution for injection - isoprenaline hydrochloride 0.2 mg/ml - cardiac therapy